Mechanism of Xenopus Cranial Neural Crest Cell Migration
非洲爪蟾颅神经嵴细胞迁移机制
基本信息
- 批准号:7575150
- 负责人:
- 金额:$ 32.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-03-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AnteriorAntisense OligonucleotidesAsthmaCell AdhesionCell DeathCell ProliferationCell surfaceCellsCephalicCleaved cellDataDevelopmentDiagnosisDisintegrinsDominant-Negative MutationDrug usageEmbryoEmbryonic DevelopmentEnvironmentEpidermisEventExtracellular MatrixFaceFibronectinsHistone H3HumanImmigrationIn Situ HybridizationIn Situ Nick-End LabelingIn VitroInjection of therapeutic agentJawLabelLateralLeadLightLinkMeasuresMesodermMessenger RNAMetalloproteasesModelingNeoplasm MetastasisNeural CrestNeural Crest CellOligonucleotidesPathway interactionsPeptide HydrolasesPeripheral Nervous SystemPhenotypePhosphorylationPositioning AttributeProteinsRelative (related person)Research PersonnelSignal TransductionSiteStructureTestingTissuesTranslationsWorkXenopusadhesion receptorbasecell motilitycraniofacialin vitro testingin vivoinhibitor/antagonistmigrationneural platenoveloverexpressionpreventprogramsprotein functionresearch studytumor
项目摘要
Proper cranial neural crest (CNC) cell migration is essential for the construction of the face, jaws and their
peripheral nervous system connections. Despite this importance, little is known about how neural crest cell
migration is regulated. During Xenopus embryo development the expression of ADAM13 (a protein
containing A Disintegrin And Metalloprotease) correlates with the migration of the cranial neural crest cells
from the lateral border of the neural plate to the ventral anterior station where they eventually form facial
structures (Alfandari et al.,1997). Our on-going analyses of cranial neural crest cells expressing a dominant
negative form of ADAM13 suggest that ADAM13 promotes and/or directs their migration in two of the three
possible pathways. Our working hypothesis is that ADAM13 cleaves a protein that normally restricts cranial
neural crest cell migration. This protein may either be inserted in the migration path as a stop signal to
prevent cell passage or be expressed at the cranial neural crest cell surface to hold the cells in place as an
anchor. To test these hypotheses and analyze whether other ADAM and related metalloproteases may also
be involved in cranial neural crest cell migration we propose the following specific Aims. This proposal has
three Aims to understand 1) if cells missing ADAM13 protein can use other ADAM and related
metalloprotease to migrate, 2) if ADAM13 functions as a "drill" to open migration pathways, 3) if ADAM13
cuts an anchor that attaches cranial neural crest cells to their environment. Using specific morpholino
oligonucleotides, we can prevent translation of ADAM proteins including ADAM13 in embryos and test how
cranial neural crest cells migrate. This can be compared to the migration of cells in which ADAM13 function
is blocked (using drug inhibitor). Using grafts we will test whether cranial neural crest cells missing ADAM13
activity can follow cells that have ADAM13. Finally, we will test if ADAM13 can cleave proteins that are
known to anchor cells down. The proposed studies will increase our understanding of events that govern
normal formation of the face, an essential step towards diagnosing and treating conditions that lead to
abnormal development. Furthermore, information about ADAM contributions to cell migration could lead to
new understanding of the function of these proteins in various cancer and metastasis. In particular these
protein (ADAM) are likely to be involved in the escape of cells from the original tumor to new sites.
适当的颅神经rest(CNC)细胞迁移对于脸部,下巴及其的构建至关重要
周围神经系统连接。尽管很重要,但对神经rest细胞的了解知之甚少
迁移受到监管。在Xenopus胚胎发育期间ADAM13的表达(蛋白质
包含崩解蛋白和金属蛋白酶)与颅神经细胞的迁移相关
从神经板的外侧边界到腹前站,最终在那里形成面部
结构(Alfandari等,1997)。我们正在进行的对颅神经rest细胞的分析,表达了主要的
ADAM13的负面形式表明ADAM13促进和/或指导其迁移到这三个中的两个
可能的途径。我们的工作假设是ADAM13裂解了通常限制颅骨的蛋白质
神经rest细胞迁移。该蛋白质可以插入迁移路径中,作为停止信号
防止细胞通过或在颅神经rest细胞表面表达,以将细胞固定在适当的位置
锚。测试这些假设并分析其他亚当和相关的金属蛋白酶是否也可能
参与颅神经rest细胞迁移,我们提出以下特定目的。该提议有
三个目的是了解1)如果缺少ADAM13蛋白的细胞可以使用其他ADAM和相关的细胞
金属蛋白酶迁移,2)如果ADAM13用作打开迁移途径的“钻”,3)如果ADAM13
切开将颅神经rest细胞连接到其环境的锚。使用特定的吗啡
寡核苷酸,我们可以防止胚胎中包括ADAM13在内的亚当蛋白的翻译,并测试如何
颅神经rest细胞迁移。可以将其与ADAM13功能的细胞迁移进行比较
被阻止(使用药物抑制剂)。使用移植物我们将测试颅神经rest细胞是否缺少ADAM13
活性可以跟随具有ADAM13的细胞。最后,我们将测试ADAM13是否可以切割蛋白质
已知可以将细胞锚定。拟议的研究将增加我们对管理事件的理解
面部正常形成,这是诊断和治疗导致条件的重要一步
异常发展。此外,有关亚当对细胞迁移贡献的信息可能会导致
对这些蛋白质在各种癌症和转移中的功能的新理解。特别是这些
蛋白质(亚当)可能参与细胞从原始肿瘤逃避到新部位的逃生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOMINIQUE R ALFANDARI其他文献
DOMINIQUE R ALFANDARI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOMINIQUE R ALFANDARI', 18)}}的其他基金
Production and characterization of monoclonal antibodies to Xenopus Proteins
非洲爪蟾蛋白单克隆抗体的生产和表征
- 批准号:
9208974 - 财政年份:2017
- 资助金额:
$ 32.8万 - 项目类别:
Production and characterization of monoclonal antibodies to Xenopus Proteins
非洲爪蟾蛋白单克隆抗体的生产和表征
- 批准号:
9897195 - 财政年份:2017
- 资助金额:
$ 32.8万 - 项目类别:
Mechanism of Xenopus Cranial Neural Crest Cell Migration
非洲爪蟾颅神经嵴细胞迁移机制
- 批准号:
7091251 - 财政年份:2006
- 资助金额:
$ 32.8万 - 项目类别:
相似国自然基金
头颈鳞癌中SETD1A反义寡核苷酸触发dsRNA/RIG-I/IFN信号和细胞焦亡诱导TAMs向M1极化的机制研究
- 批准号:82303133
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
反义寡核苷酸—核酸适配体嵌合体的靶向分子设计与催化降解机理研究
- 批准号:22307124
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
反义寡核苷酸诱导一种新型RNA编辑的研究
- 批准号:32271346
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
载反义寡核苷酸超声微泡靶向α-突触核蛋白改善帕金森病病理的实验研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
载反义寡核苷酸超声微泡靶向α-突触核蛋白改善帕金森病病理的实验研究
- 批准号:82201408
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Therapy of Pulmonary Diseases with Peptide-Oligonucleotide Conjugates and Small Molecule Enhancing Compounds
用肽-寡核苷酸缀合物和小分子增强化合物治疗肺部疾病
- 批准号:
10222808 - 财政年份:2019
- 资助金额:
$ 32.8万 - 项目类别: